Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has entered into an agreement to acquire Oxipit, UAB, a Lithuanian company specializing in AI-based solutions for ...

Oxipit, a developer of clinically validated AI solutions for radiology, announced that Sectra (STO: SECT B) has signed ...

Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it is ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data ...

Late-stage gene therapy pipeline for rare and retinal diseases advancing toward key catalysts RGX-202 for Duchenne muscular dystrophy: New Phase I/II data at ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Capital Infusion -- $15.9 million raised from Coastland Capital and Janus Henderson through a private placement, with a potential additional $15 million tranche contingent on milestone achievement.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...